Clene Inc. Files 8-K for October 17, 2025

TL;DR

Clene Inc. filed a routine 8-K on 10/17/25. No major news, just standard SEC reporting.

AI Summary

Clene Inc. filed an 8-K on October 17, 2025, reporting on other events and financial statements. The company, formerly known as Chelsea Worldwide Inc. until August 27, 2020, is incorporated in Delaware and headquartered in Salt Lake City, Utah. The filing does not disclose specific financial figures or material events beyond its routine reporting nature.

Why It Matters

This 8-K filing indicates Clene Inc. is providing updates to the SEC, which is standard for publicly traded companies. Investors should review the full filing for any specific details that may impact the company's operations or stock.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report with no indication of significant new events, financial distress, or major corporate actions.

Key Players & Entities

• Clene Inc. (company) — Registrant
• Chelsea Worldwide Inc. (company) — Former company name
• August 27, 2020 (date) — Date of name change
• October 17, 2025 (date) — Date of report
• Delaware (jurisdiction) — State of incorporation
• Salt Lake City, Utah (location) — Principal executive offices

FAQ

Key Financial Figures

• $0.0001 — nge on which registered Common Stock, $0.0001 par value CLNN The Nasdaq Capital M
• $230.00 — rtieth of one share of Common Stock for $230.00 per share CLNNW The Nasdaq Capital
• $25,000,000 — ng an aggregate offering price of up to $25,000,000 from time to time through the Placement
• $6,119,859 — aggregate sales price of approximately $6,119,859 under the Equity Distribution Agreement
• $18,880,000 — tribution Agreement for an aggregate of $18,880,000 of additional shares of Common Stock. A

Filing Documents

• clnn20251013_8k.htm (8-K) — 29KB
• ex_869309.htm (EX-5.1) — 14KB
• hklogo35px.jpg (GRAPHIC) — 8KB
• 0001437749-25-031277.txt ( ) — 205KB
• clnn-20251017.xsd (EX-101.SCH) — 4KB
• clnn-20251017_def.xml (EX-101.DEF) — 14KB
• clnn-20251017_lab.xml (EX-101.LAB) — 18KB
• clnn-20251017_pre.xml (EX-101.PRE) — 14KB
• clnn20251013_8k_htm.xml (XML) — 5KB

01 Other Events

Item 8.01 Other Events. On April 28, 2025, Clene Inc. (the "Company") entered into an equity distribution agreement (the "Equity Distribution Agreement") with Canaccord Genuity LLC as placement agent (the "Placement Agent") to offer and sell shares of its common stock, par value $0.0001 per share ("Common Stock"), having an aggregate offering price of up to $25,000,000 from time to time through the Placement Agent. Prior to the date hereof, the Company sold shares of common stock having an aggregate sales price of approximately $6,119,859 under the Equity Distribution Agreement. On October 17, 2025, the Company filed a prospectus supplement under the Equity Distribution Agreement for an aggregate of $18,880,000 of additional shares of Common Stock. A copy of the legal opinion of Holland & Knight LLP, relating to the validity of the shares in connection with the Equity Distribution Agreement is filed as Exhibit 5.1 to this Current Report on Form 8-K and is incorporated herein by reference.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Exhibit Description 5.1 Opinion of Holland & Knight LLP. 23.1 Consent of Holland & Knight LLP (contained in Exhibit 5.1). 104 Cover Page Interactive Data File (formatted as Inline XBRL). 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. CLENE INC. Date: October 17, 2025 By: /s/ Robert Etherington Robert Etherington President and Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR